|
Oct 1
|
Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
|
|
Sep 4
|
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
|
|
Jul 20
|
Organogenesis Holdings Inc. (ORGO): Is It Among the Best NASDAQ Penny Stocks to Invest In Now?
|
|
Jun 8
|
With 38% ownership, Organogenesis Holdings Inc. (NASDAQ:ORGO) insiders have a lot riding on the company's future
|
|
May 12
|
Organogenesis Holdings First Quarter 2024 Earnings: Beats Expectations
|
|
May 10
|
Organogenesis Holdings Inc. Reports First Quarter 2024 Results: A Close Look at Financial ...
|
|
May 10
|
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Q1 2024 Organogenesis Holdings Inc Earnings Call
|
|
May 10
|
Organogenesis (ORGO) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
|
|
May 2
|
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
|
|
Apr 16
|
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
|
|
Apr 3
|
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
|
|
Feb 8
|
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
|
|
Jan 15
|
Are You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great Choice
|
|
Jan 14
|
Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested five years ago
|
|
Dec 28
|
Organogenesis (ORGO) is a Great Momentum Stock: Should You Buy?
|
|
Dec 18
|
Organogenesis Holdings Inc. (NASDAQ:ORGO) Surges 42% Yet Its Low P/S Is No Reason For Excitement
|
|
Dec 7
|
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Stock Is Going Strong: Have Financials A Role To Play?
|
|
Sep 28
|
Why Shares of Organogenesis Holdings Are Up Thursday
|